UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases

Annals of allergy, asthma, & immunology, 1998-11, Vol.81 (5), p.401-405

1998

Volltextzugriff (PDF)

Electromagnetic scattering by mixed conductor-dielectric bodies of arbitrary shape

IEEE transactions on antennas and propagation, 2006-08, Vol.54 (8), p.2402-2407

2006

Volltextzugriff (PDF)

Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology

Annals of allergy, asthma, & immunology, 1998-11, Vol.81 (5), p.401-405

1998

Volltextzugriff (PDF)

Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis

The New England journal of medicine, 2006-10, Vol.355 (14), p.1445-1455

2006

Volltextzugriff (PDF)

Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs

Clinical and translational allergy, 2020-04, Vol.10 (1), p.11-n/a, Article 11

2020

Volltextzugriff (PDF)

Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure

Allergy (Copenhagen), 2014-05, Vol.69 (5), p.617-623

2014

Volltextzugriff (PDF)

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

The New England journal of medicine, 2020-03, Vol.382 (13), p.1232-1243

2020

Volltextzugriff (PDF)

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

The New England journal of medicine, 2022-05, Vol.386 (19), p.1793-1803

2022

Volltextzugriff (PDF)

Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity

Journal of allergy and clinical immunology, 2000-07, Vol.106 (1), p.124-134

2000

Volltextzugriff (PDF)

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study

The Lancet infectious diseases, 2012, Vol.12 (1), p.27-35

2012

Volltextzugriff (PDF)

Ragweed Immunotherapy in Adult Asthma

The New England journal of medicine, 1996-02, Vol.334 (8), p.501-507

1996

Volltextzugriff (PDF)

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults

Clinical infectious diseases, 2008-06, Vol.46 (11), p.1769-1781

2008

Volltextzugriff (PDF)

Treatment of cat allergy with T-cell reactive peptides

American journal of respiratory and critical care medicine, 1996-12, Vol.154 (6 Pt 1), p.1623-1628

1996

Volltextzugriff (PDF)

Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection

The Journal of infectious diseases, 2005-03, Vol.191 (5), p.654-665

2005

Volltextzugriff (PDF)

Descriptive Analysis of Frequency and Severity of Meat Sensitivity in Tick-bitten Patients in a Northern Virginia Allergy Practice

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB186-AB186

2011

Volltextzugriff (PDF)

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

The lancet HIV, 2020-01, Vol.7 (1), p.e16-e26

2020

Volltextzugriff (PDF)

Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial

The lancet HIV, 2023-08, Vol.10 (8), p.e497-e505

2023

Volltextzugriff (PDF)

IFN-α inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release

Journal of allergy and clinical immunology, 2003-11, Vol.112 (5), p.944-950

2003

Volltextzugriff (PDF)

Ragweed Allergy Immunotherapy Tablet Reduces Nasal and Ocular Symptoms of Allergic Rhinoconjunctivitis Over the Peak Ragweed Pollen Season in North America

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB249-AB249

2012

Volltextzugriff (PDF)

Efficacy and Safety of a Novel Ragweed Allergy Immunotherapy Tablet (AIT) During Peak Season in North America

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB143-AB143

2012

Volltextzugriff (PDF)

Dose-related Effects of Ragweed Allergy Immunotherapy Tablet on Nasal and Ocular Symptoms of Allergic Rhinoconjunctivitis During the Peak Ragweed Pollen Seasons in Europe and North America

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB47-AB47

2012

Volltextzugriff (PDF)

Systemic Reactions to Allergen Immunotherapy in a Community Practice

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB195-AB195

2012

Volltextzugriff (PDF)

Timothy Grass Allergy Immunotherapy Tablets Reduce Nasal and Ocular Symptoms Associated With Allergic Rhinoconjunctivitis During Grass Pollen Season in North American Children and Adults: 2 Randomized, Placebo-Controlled Trials

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB144-AB144

2012

Volltextzugriff (PDF)

Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy

Journal of allergy and clinical immunology, 2001-08, Vol.108 (2), p.191-197

2001

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(63)
Tagungsberichte
(2)

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases

Electromagnetic scattering by mixed conductor-dielectric bodies of arbitrary shape

Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology

Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis

Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs

Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study

Ragweed Immunotherapy in Adult Asthma

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults

Treatment of cat allergy with T-cell reactive peptides

Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection

Descriptive Analysis of Frequency and Severity of Meat Sensitivity in Tick-bitten Patients in a Northern Virginia Allergy Practice

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial

IFN-α inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release

Ragweed Allergy Immunotherapy Tablet Reduces Nasal and Ocular Symptoms of Allergic Rhinoconjunctivitis Over the Peak Ragweed Pollen Season in North America

Efficacy and Safety of a Novel Ragweed Allergy Immunotherapy Tablet (AIT) During Peak Season in North America

Dose-related Effects of Ragweed Allergy Immunotherapy Tablet on Nasal and Ocular Symptoms of Allergic Rhinoconjunctivitis During the Peak Ragweed Pollen Seasons in Europe and North America

Systemic Reactions to Allergen Immunotherapy in a Community Practice

Timothy Grass Allergy Immunotherapy Tablets Reduce Nasal and Ocular Symptoms Associated With Allergic Rhinoconjunctivitis During Grass Pollen Season in North American Children and Adults: 2 Randomized, Placebo-Controlled Trials

Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy

Suchergebnisse filtern